Search

Your search keyword '"V. Di Martino"' showing total 90 results

Search Constraints

Start Over You searched for: Author "V. Di Martino" Remove constraint Author: "V. Di Martino" Topic business.industry Remove constraint Topic: business.industry
90 results on '"V. Di Martino"'

Search Results

1. Qualitative Objectives to Preserve, Protect and Valorise the Lombardy Rural Landscapes in the Regional Landscape Plan

2. AF.87 RESIST-HCV CRITERIA ARE ABLE TO RULE OUT ESOPHAGEAL VARICES PROGRESSION IN PATIENTS WITH HCV CIRRHOSIS TREATED BY DIRECT-ACTING ANTIVIRAL AGENTS(DAAS)

4. Abstracts of the 33rd International Austrian Winter Symposium

5. PNPLA3 rs738409 C >G variant is associated with a higher risk of liver fibrosis progression assessed by FIB-4 and stiffness by fibroscan in patients with non-alcoholic fatty liver disease

6. Impact of postoperative events on the occurrence of anastomotic biliary strictures after liver transplantation

8. AB0438 Safety of tnf blockers in case of non-alcoholic fatty liver disease and cirrhosisa systematic review

9. Safety of sofosbuvir-based regimens after liver transplantation longitudinal assessment of renal function in the prospective ANRS CO23 CUPILT study

10. Impact of Cytomegalovirus infection on the outcome of patients with cirrhosis: a preliminary study

11. OC-0067 Continuous Positive Airway Pressure (CPAP): an innovative respiratory gating in lymphoma patients

12. Should we keep using Ribavirin to Treat Hepatitis C Recurrence after Liver Transplantation? Results from the CO23 ANRS Cupilt Study

13. Daclatasvir plus Sofosbuvir with or without Ribavirin in Patients with HCV Infection and Decompensated Cirrhosis: Interim Analysis of a French Multicentre Compassionate use Programme

14. Long‐term outcome of chronic hepatitis C in a population‐based cohort and impact of antiviral therapy: a propensity‐adjusted analysis

15. P.09.17 PNPLA3 RS738409 POLYMORPHISM PREDICTS THE DEVELOPMENT AND THE SEVERITY OF HEPATIC STEATOSIS, BUT NOT METABOLIC SYNDROME, IN PATIENTS WITH CELIAC DISEASE

16. Le syndrome hépatopulmonaire

17. L’hepar lobatum carcinomatosum : une cause rare d’hypertension portale compliquant les métastases hépatiques d’un carcinome mammaire

18. Coeliac disease in chronic hepatitis C: a French multicentre prospective study

19. Continuous infusion of high-dose omeprazole is more effective than standard-dose omeprazole in patients with high-risk peptic ulcer bleeding: a retrospective study

20. O109 : Treatment of severe HCV-recurrence after liver transplantation using sofosbuvir-based regimens: The ANRS CO23 CUPILT study

21. G15 : The association of sofosbuvir and daclatasvir for treating severe recurrence of HCV infection after liver transplantation: Results from a large french prospective multicentric ANRS CO23 CUPILT cohort

22. LP05 : Daclatasvir plus sofosbuvir with or without ribavirin in patients with HCV genotype 3 infection: Interim analysis of a french multicenter compassionate use program

23. P0768 : Late mortality in treatment-experienced cirrhotic patients treated with triple therapy including boceprevir or telaprevir in a real-life cohort - ANRS Co 20 cupic

24. Flumazenil vs. placebo in hepatic encephalopathy in patients with cirrhosis: a meta-analysis

25. A randomized trial of 6-month norfloxacin therapy in patients with Child-Pugh class C cirrhosis

26. Acute colitis: differential diagnosis using multidetector CT

27. Thrombose portale par diffusion de cyanoacrylate au décours de l’obturation de varices gastriques hémorragiques

28. Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients

29. Cyamamezine-induced acute hepatitis after unique massive intake

30. A case of isolated splenic infarction associated with a foramen ovale and an interatrial septal aneurysm

31. Severe acute pancreatitis related to the use of adefovir in a liver transplant recipient

32. P0821 : Are extended durations and/or ribavirin useful for genotype 1 (G1) cirrhotic patients who receive DAAs combination? A meta-analysis of randomized controlled trials (RCTS)

33. P0205 : Management of gastric varices: A french national survey

34. P0142 : Mortality risk factors in cirrhotic patients in Intensive Care Unit: A monocentric retrospective study at Besançon’s University Hospital from 2002 to 2014

35. P0132 : External validation of the CLIF-SOFA in cirrhotic patients admitted to intensive care units (ICUS): A meta-analysis

36. Nicardipine as antihypertensive therapy in liver transplant recipients: Results of long-term use

37. Renal Dysfunction in Liver Transplant Patients Treated with Sofosbuvir Based-Regimen for HCV Recurrence: Results from a Large French Prospective Multicentric ANRS CO23 Cupilt

38. Sofosbuvir-Based-Regimen for HCV Recurrence after Combined Liver-Kidney Transplantation : Results from the ANRS CO23 Cupilt Study

39. P455 BACTERIAL ENDOCARDITIS IN PATIENTS WITH CIRRHOSIS: A MULTICENTER RETROSPECTIVE STUDY OF 78 CASES

40. Personalized management of patients with inoperable alveolar echinococcosis undergoing treatment with albendazole: usefulness of positron-emission-tomography combined with serological and computed tomography follow-up

41. WTB: A token based wireless communication over 802.11b

42. Assessing adrenal function in cirrhotic patients: is there a reliable test?

43. Is Bleeding Time Measurement Useful for Choosing the Liver Biopsy Route? The Results of a Pragmatic, Prospective Multicentric Study in 219 Patients

44. Specific phenotype associated with diabetes mellitus secondary to chronic hepatitis C infection

45. P0149 : Six-month mortality of cirrhotic patients who survived intensive care: A meta-analysis

46. P0150 : Liver cirrhosis is independently associated with mortality in patients with bacterial endocarditis: Results of a case control multicenter study of 202 cases

47. 765 TWELVE-MONTHS ENTECAVIR LONGITUDINAL CHANGES IN LIVER FIBROSIS, ACTIVITY AS PER FibroTest-FibroMax AND LIVER STIFFNESS MEASUREMENTS IN CHRONIC HEPATITIS B. STEATOSIS IMPACT ON FIBROSIS REGRESSION

48. Mobile adaptive information systems on MANET: what we need as basic layer?

49. Sub optimal scheduling in a GRID using genetic algorithms

50. 712 PNPLA 3 RS738409 GG HOMOZYGOTE STATUS IS ASSOCIATED WITH INCREASED RISK OF HEPATOCELLULAR CARCINOMA IN CIRRHOTIC PATIENTS

Catalog

Books, media, physical & digital resources